Modernizing Drug Enforcement Act of 2019
Latest action · May 31, 2019 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 8, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Modernizing Drug Enforcement Act of 2019
This bill deems a drug or substance that acts as an opioid mu receptor agonist (e.g., morphine) to be in schedule I of the Controlled Substances Act, subject to certain exceptions. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
Cosponsors 1
Members who signed on, in the order they did. All signed on May 8, 2019.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NY | Thomas R. Suozzi | Original | May 8, 2019 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 8, 2019 |
| Health Subcommittee | Referred May 9, 2019 | |
| House | Judiciary Committee | Referred May 8, 2019 |
| Crime and Federal Government Surveillance Subcommittee | Referred May 31, 2019 |
Actions 4
Everything that happened, newest first.
- May 31, 2019Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
- May 9, 2019Referred to the Subcommittee on Health.
- May 8, 2019Introduced in House
- May 8, 2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 76, May 8, 2019, page H3502.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R45948 | The Controlled Substances Act (CSA): A Legal Overview for the 119th Congress | Report | Jan 22, 2025 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Controlled Substances Act to deem drugs or other substances that act as mu opioid receptor agonists to be in schedule I, subject to exceptions for substances intended for legitimate medical or research use, and for other purposes.
- Short Title(s) as Introduced
- Modernizing Drug Enforcement Act of 2019
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
Text 1
Each version as it was printed, newest first.
- May 8, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.